AQR Arbitrage’s United Therapeutics UTHR Stock Holding History

AQR Arbitrage’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,970	Closed	-$1.21M	–	1360
2020 Q4	$1.21M	Buy	+7,970	New	+$1.05M	0.04%	382

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

AQR Arbitrage's UTHR Position: Q1 2021 in Review

AQR Arbitrage sold out of United Therapeutics (UTHR) in Q1 2021, closing a stake of 7,970 shares — an estimated $1.21M sold.

AQR Arbitrage first reported a position in UTHR in Q4 2020 and held it in 1 quarter. The position peaked at $1.21M in Q4 2020. 391 funds tracked by Wall St. Rank hold UTHR as of Q1 2021.

AQR Arbitrage reported no remaining United Therapeutics position as of Q1 2021 after selling out during the quarter.
AQR Arbitrage sold 7,970 United Therapeutics shares in Q1 2021, an estimated $1.21M.
AQR Arbitrage first reported a position in United Therapeutics in Q4 2020 and held it in 1 quarter.
AQR Arbitrage's United Therapeutics position peaked at $1.21M in Q4 2020.
391 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2021.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.